|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.66 USD | +0.05% |
|
-3.68% | -19.36% |
| 03-05 | Tenaya Therapeutics and Alnylam Pharmaceuticals Enter Research Collaboration Agreement | CI |
| 03-05 | Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 47.82x | 19.04x | 7.01x | 33.57x | 34.83x | 42.53B | ||
| 0.67% | 0.74% | 29.11x | 17.94x | 10.96x | 22.02x | 23.36x | 885B | ||
| 2.2% | 2.33% | 24.47x | 6.62x | 5.94x | 16.17x | 17.86x | 579B | ||
| 3.01% | 3.13% | 24.99x | 72.15x | 6.83x | 13.71x | 14.06x | 407B | ||
| 2.95% | 3.03% | 18.18x | 6.35x | 4.48x | 11.08x | 12.6x | 350B | ||
| 2.79% | 2.91% | 21.57x | 6.38x | 5.8x | 14.34x | 15.34x | 302B | ||
| 1.71% | 1.82% | 24.42x | 5.55x | 5.09x | 14.1x | 15.13x | 301B | ||
| 2.92% | 3.01% | 27.07x | 5.06x | 4.75x | 14.84x | 17.52x | 286B | ||
| 2.72% | 2.9% | 24.86x | 16.7x | 6.31x | 11.22x | 14.33x | 199B | ||
| 2.26% | 2.51% | 19.95x | 6.76x | 6.07x | 10.98x | 12.93x | 179B | ||
| 4.35% | 4.55% | 11.71x | 5.02x | 4.25x | 8.78x | 10.27x | 171B | ||
| 6.5% | 6.53% | 12.65x | 1.69x | 3.2x | 7.65x | 9.07x | 154B | ||
| 4.17% | 4.29% | 12.05x | 5.27x | 3.17x | 8.52x | 9.15x | 123B | ||
| -.--% | -.--% | 26.04x | 5.12x | 7.8x | 17.52x | 18.1x | 116B | ||
| 3.4% | 3.73% | 12.79x | 4.34x | 2.77x | 8.02x | 9.2x | 109B | ||
| 5.53% | 5.9% | 11.7x | 1.18x | 2.2x | 7.29x | 7.87x | 107B | ||
| 2.64% | 1.43% | 36.86x | 7.97x | 11.93x | 23.45x | 25x | 100B | ||
| 3.52% | 3.58% | 51.29x | 1.28x | 2.85x | 10.57x | 30.03x | 57B | ||
| 0.47% | 0.54% | 42.79x | 6.04x | 9.97x | 33.79x | 38.68x | 53.42B | ||
| 1.88% | 2.11% | 21.41x | 2.04x | 3.71x | 14.69x | 16.44x | 44.97B | ||
| Average | 2.68% | 2.75% | 25.09x | 10.12x | 5.76x | 15.12x | 17.59x | 228.34B | |
| Weighted average by Cap. | 2.42% | 2.51% | 24.00x | 14.44x | 6.54x | 15.24x | 16.92x |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















